[AEONCR] YoY Cumulative Quarter Result on 31-Aug-2021 [#2]

Stock
[AEONCR] AEON CREDIT SERVICE (M) BHD
Announcement Date
28-Sep-2021
Admission Sponsor
-
Sponsor
-
Financial Year
28-Feb-2022
Quarter
31-Aug-2021 [#2]
Profit Trend
QoQ- 46.28%
YoY- 205.52%
Quarter Report
Latest QR
Upcoming QR
AEONCR's Result
AEONCR's Financial Summary
View:
Show?
Cumulative Result
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
Revenue 1,063,688 924,404 789,742 785,441 753,845 783,034 657,810 8.33%
PBT 245,961 291,145 315,582 318,003 113,572 179,544 238,996 0.47%
Tax -68,390 -71,593 -76,864 -79,428 -35,483 -45,817 -59,121 2.45%
NP 177,571 219,552 238,718 238,575 78,089 133,727 179,875 -0.21%
-
NP to SH 177,571 219,552 238,718 238,575 78,089 133,727 179,875 -0.21%
-
Tax Rate 27.81% 24.59% 24.36% 24.98% 31.24% 25.52% 24.74% -
Total Cost 886,117 704,852 551,024 546,866 675,756 649,307 477,935 10.82%
-
Net Worth 2,726,363 2,502,015 2,231,389 1,894,383 1,524,188 1,549,719 1,392,929 11.83%
Dividend
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
Div 72,754 72,762 72,762 72,762 23,488 56,806 55,542 4.59%
Div Payout % 40.97% 33.14% 30.48% 30.50% 30.08% 42.48% 30.88% -
Equity
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
Net Worth 2,726,363 2,502,015 2,231,389 1,894,383 1,524,188 1,549,719 1,392,929 11.83%
NOSH 510,554 255,307 255,307 255,307 253,651 250,893 249,735 12.64%
Ratio Analysis
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
NP Margin 16.69% 23.75% 30.23% 30.37% 10.36% 17.08% 27.34% -
ROE 6.51% 8.78% 10.70% 12.59% 5.12% 8.63% 12.91% -
Per Share
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
RPS 208.34 362.07 309.33 307.64 295.27 306.70 263.52 -3.83%
EPS 34.78 84.02 91.53 91.47 28.60 48.73 69.45 -10.87%
DPS 14.25 28.50 28.50 28.50 9.20 22.25 22.25 -7.15%
NAPS 5.34 9.80 8.74 7.42 5.97 6.07 5.58 -0.72%
Adjusted Per Share Value based on latest NOSH - 255,307
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
RPS 208.37 181.09 154.71 153.87 147.68 153.40 128.86 8.33%
EPS 34.79 43.01 46.76 46.74 15.30 26.20 35.24 -0.21%
DPS 14.25 14.25 14.25 14.25 4.60 11.13 10.88 4.59%
NAPS 5.3409 4.9014 4.3713 3.7111 2.9859 3.0359 2.7287 11.83%
Price Multiplier on Financial Quarter End Date
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
Date 30/08/24 30/08/23 30/08/22 30/08/21 28/08/20 30/08/19 30/08/18 -
Price 7.10 11.00 14.10 12.06 9.04 15.00 15.10 -
P/RPS 3.41 3.04 4.56 3.92 3.06 4.89 5.73 -8.27%
P/EPS 20.41 12.79 15.08 12.91 29.56 28.64 20.96 -0.44%
EY 4.90 7.82 6.63 7.75 3.38 3.49 4.77 0.44%
DY 2.01 2.59 2.02 2.36 1.02 1.48 1.47 5.34%
P/NAPS 1.33 1.12 1.61 1.63 1.51 2.47 2.71 -11.17%
Price Multiplier on Announcement Date
31/08/24 31/08/23 31/08/22 31/08/21 31/08/20 31/08/19 31/08/18 CAGR
Date 26/09/24 26/09/23 29/09/22 28/09/21 29/09/20 26/09/19 04/10/18 -
Price 7.35 11.44 13.48 11.88 10.60 14.96 15.86 -
P/RPS 3.53 3.16 4.36 3.86 3.59 4.88 6.02 -8.50%
P/EPS 21.13 13.30 14.42 12.71 34.66 28.56 22.01 -0.67%
EY 4.73 7.52 6.94 7.87 2.89 3.50 4.54 0.68%
DY 1.94 2.49 2.11 2.40 0.87 1.49 1.40 5.58%
P/NAPS 1.38 1.17 1.54 1.60 1.78 2.46 2.84 -11.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment